Mirum Pharmaceuticals Inc (MIRM)

Feb 25, 2026

Mirum Pharmaceuticals Reports Strong Q4 2025 Earnings and 2026 Guidance - Intellectia AI

Feb 25, 2026

Feb 25, 2026

Mirum Pharmaceuticals (MIRM) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance

Feb 25, 2026

Feb 25, 2026

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Feb 25, 2026

Feb 25, 2026

Mirum Pharmaceuticals Files For Offering Of Up To 8.96 Million Shares Of Common Stock By The Selling Stockholders - TradingView

Feb 25, 2026

Feb 25, 2026

Mirum (MIRM) Q4 2025 Earnings Call Transcript - AOL.com

Feb 25, 2026

Feb 25, 2026

According to the latest filing submitted to the U.S. Securities and Exchange Commission (SEC), Mirum Pharmaceuticals, Inc. has officially registered a public offering plan of common stock initiated by selling shareholders. - Bitget

Feb 25, 2026

Feb 25, 2026

Earnings call transcript: Mirum Pharmaceuticals’ Q4 2025 revenue exceeds expectations - Investing.com

Feb 25, 2026

Feb 25, 2026

Mirum Pharmaceuticals Q4 Earnings Call Highlights - Yahoo Finance

Feb 25, 2026

Feb 25, 2026

Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2025 Results and Provides Business Update - Business Wire

Feb 25, 2026

Feb 25, 2026

Mirum Pharmaceuticals earnings up next as pipeline readouts loom - Investing.com

Feb 25, 2026

Feb 25, 2026

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A Biotech Powerhouse with 9.63% Potential Upside - DirectorsTalk Interviews

Feb 25, 2026

Feb 24, 2026

Is It Too Late To Consider Mirum Pharmaceuticals (MIRM) After Its 115% One-Year Surge? - Yahoo Finance

Feb 24, 2026

Feb 24, 2026

Insights Ahead: Mirum Pharmaceuticals's Quarterly Earnings - Benzinga

Feb 24, 2026

Feb 23, 2026

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences - bdtonline.com

Feb 23, 2026

Feb 20, 2026

Will Mirum Pharmaceuticals Inc. stock hit new highs in YEARJuly 2025 Snapshot & Weekly High Return Stock Forecasts - mfd.ru

Feb 20, 2026

Feb 20, 2026

Mirum Pharmaceuticals (NASDAQ:MIRM) Research Coverage Started at Royal Bank Of Canada - Defense World

Feb 20, 2026

Feb 19, 2026

Portfolio Recap: Will Mirum Pharmaceuticals Inc stock hit new highs in YEARJuly 2025 Review & Risk Controlled Daily Plans - baoquankhu1.vn

Feb 19, 2026

Feb 19, 2026

Mirum Pharmaceuticals (NASDAQ:MIRM) Raised to "Moderate Buy" at Royal Bank Of Canada - MarketBeat

Feb 19, 2026

Feb 19, 2026

Mirum Pharmaceuticals stock reaches all-time high at 106.27 USD By Investing.com - Investing.com Canada

Feb 19, 2026

Feb 18, 2026

Earnings Recap: Can Mirum Pharmaceuticals Inc benefit from deglobalizationJuly 2025 Trends & Free Community Consensus Stock Picks - baoquankhu1.vn

Feb 18, 2026

Feb 18, 2026

Mirum Pharmaceuticals to Announce Fourth Quarter and Year-End 2025 Financial Results and Host Conference Call on February 25, 2026 - Bluefield Daily Telegraph

Feb 18, 2026

Feb 18, 2026

Drugmaker Mirum sets Feb. 25 call on 2025 results - Stock Titan

Feb 18, 2026

Feb 18, 2026

User - The Chronicle-Journal

Feb 18, 2026

Feb 18, 2026

RBC Capital Initiates Coverage of Mirum Pharmaceuticals (MIRM) with Outperform Recommendation - Nasdaq

Feb 18, 2026

Feb 18, 2026

Mirum Pharmaceuticals (NASDAQ:MIRM) Sets New 52-Week HighTime to Buy? - MarketBeat

Feb 18, 2026

Feb 18, 2026

Mirum Can Sustain Revenue Growth with Multiple Catalysts, RBC Says - marketscreener.com

Feb 18, 2026

Feb 18, 2026

Mirum Pharmaceuticals stock reaches all-time high at 106.27 USD - Investing.com

Feb 18, 2026

Feb 18, 2026

Mirum Pharmaceuticals, Inc. (MIRM) Earnings Expected to Grow: What to Know Ahead of Q4 Release - Yahoo Finance

Feb 18, 2026

Feb 18, 2026

Mirum Pharmaceuticals (MIRM) Expected to Announce Earnings on Wednesday - MarketBeat

Feb 18, 2026

Feb 17, 2026

Saira Ramasastry, Mirum director, sells $204k in shares By Investing.com - Investing.com Canada

Feb 17, 2026

Feb 17, 2026

Saira Ramasastry, Mirum director, sells $204k in shares - Investing.com

Feb 17, 2026

Feb 17, 2026

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A Biotech Gem with 11.25% Upside Potential - DirectorsTalk Interviews

Feb 17, 2026

Feb 16, 2026

TimesSquare Capital Management LLC Makes New $22.04 Million Investment in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat

Feb 16, 2026

Feb 16, 2026

Is Mirum Pharmaceuticals Inc. a turnaround storyDollar Strength & Real-Time Stock Price Movement Reports - mfd.ru

Feb 16, 2026

Feb 14, 2026

Why Mirum Pharmaceuticals Inc. stock is trending among retail traders - mfd.ru

Feb 14, 2026

Feb 14, 2026

MIRUM PHARMACEUTICALS INC (NASDAQ:MIRM) Embodies the Minervini Growth Momentum Strategy - ChartMill

Feb 14, 2026

Feb 13, 2026

What are analysts’ price targets for Mirum Pharmaceuticals Inc.Earnings Summary Report & Weekly Sector Rotation Insights - mfd.ru

Feb 13, 2026

Feb 13, 2026

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Feb 13, 2026

Feb 12, 2026

Will Mirum Pharmaceuticals Inc. benefit from AI trendsShare Buyback & Expert Verified Stock Movement Alerts - mfd.ru

Feb 12, 2026

Feb 11, 2026

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - MEXC

Feb 11, 2026

Feb 10, 2026

Mirum Pharmaceuticals Grants Stock Awards to New Employees - Intellectia AI

Feb 10, 2026

Feb 10, 2026

Mirum Pharmaceuticals Inc (NASDAQ:MIRM) Offers a High-Growth Momentum and Technical Breakout Setup - ChartMill

Feb 10, 2026

Feb 10, 2026

Candriam S.C.A. Grows Stock Holdings in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat

Feb 10, 2026

Feb 09, 2026

Mirum Pharmaceuticals expands portfolio in rare disease drug focus - Traders Union

Feb 09, 2026

Feb 08, 2026

Gap Down: Can Mirum Pharmaceuticals Inc benefit from deglobalizationJuly 2025 PreEarnings & Fast Entry Momentum Alerts - baoquankhu1.vn

Feb 08, 2026

Feb 07, 2026

Health Canada approves Livmarli for PFIC and ALGS - The Pharma Letter

Feb 07, 2026

Feb 07, 2026

Mirum Pharmaceuticals, Inc. $MIRM Shares Purchased by Penserra Capital Management LLC - MarketBeat

Feb 07, 2026

Feb 06, 2026

Sentiment Review: Is Mirum Pharmaceuticals Inc a turnaround storyFed Meeting & Safe Entry Trade Signal Reports - baoquankhu1.vn

Feb 06, 2026

Feb 06, 2026

Health Canada LIVMARLI Decision And Bluejay Deal Shape Mirum Outlook - Yahoo Finance

Feb 06, 2026

Feb 05, 2026

Mirum Pharmaceuticals says Health Canada authorizes Livmarli for cholestatic pruritus in progressive familial intrahepatic cholestasis (PFIC) patients - marketscreener.com

Feb 05, 2026

Feb 05, 2026

Mirum Pharmaceuticals Announces Health Canada Authorization of LIVMARLI® Tablet Formulation for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome - BioSpace

Feb 05, 2026

Feb 05, 2026

Mirum Pharmaceuticals Stumbles on Health Canada Approval - Baystreet.ca

Feb 05, 2026

Feb 05, 2026

Mirum Pharmaceuticals' Tablet Formulation of its Cholestasic Pruritus Treatment Livmarli Approved in Canada - marketscreener.com

Feb 05, 2026

Feb 05, 2026

for the Treatment of Cholestatic Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis (PFIC) - Business Wire

Feb 05, 2026

Feb 04, 2026

Is Mirum Pharmaceuticals on a Strong Path to Profitability? - AOL.com

Feb 04, 2026

Feb 04, 2026

Hot Picks: Small-cap pharma stocks in focus as key drug approvals near - BNN Bloomberg

Feb 04, 2026